ARTICLE | Financial News

iOmx raises EUR 40M series A round

September 22, 2016 7:00 AM UTC

Immuno-oncology company iOmx Therapeutics AG (Martinsried, Germany) raised EUR 40 million ($44.6 million) in a series A round co-led by MPM Capital and Sofinnova Partners. Other investors included Wellington Partners and the Merck Ventures subsidiary of Merck KGaA (Xetra:MRK). ...